Cargando…
Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
In this study, we present the synthesis, kinetic studies of inhibitory activity toward aldo-keto reductase 1C (AKR1C) enzymes, and anticancer potential toward chemoresistant ovarian cancer of 10 organoruthenium compounds bearing diketonate (1–6) and hydroxyquinolinate (7–10) chelating ligands with t...
Autores principales: | Kljun, Jakob, Pavlič, Renata, Hafner, Eva, Lipec, Tanja, Moreno-Da Silva, Sara, Tič, Primož, Turel, Iztok, Büdefeld, Tomaž, Stojan, Jure, Rižner, Tea Lanišnik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9403717/ https://www.ncbi.nlm.nih.gov/pubmed/36034868 http://dx.doi.org/10.3389/fphar.2022.920379 |
Ejemplares similares
-
Enzymes of the AKR1B and AKR1C Subfamilies and Uterine Diseases
por: Rižner, Tea Lanišnik
Publicado: (2012) -
Synthesis and evaluation of AKR1C inhibitory properties of A-ring halogenated oestrone derivatives
por: Sinreih, Maša, et al.
Publicado: (2021) -
AKR1B1 and AKR1B10 as Prognostic Biomarkers of Endometrioid Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2021) -
AKR1C3 Is Associated with Better Survival of Patients with Endometrial Carcinomas
por: Hojnik, Marko, et al.
Publicado: (2020) -
Diagnostic and prognostic values of AKR1C3 and AKR1D1 in hepatocellular carcinoma
por: Zhu, Pengfei, et al.
Publicado: (2021)